Literature DB >> 17242955

Altered collagen homeostasis in human aortic smooth muscle cells (HAoSMCs) induced by aldosterone.

Michael Gekle1, Sigrid Mildenberger, Ruth Freudinger, Claudia Grossmann.   

Abstract

The importance of aldosterone for cardiovascular diseases is well established. Most of the adverse effects seem to originate from its ability to produce vascular injury, including fibrosis. It is currently under debate whether aldosterone per se is able to induce fibrosis or whether it acts as a cofactor under pathological conditions. We tested whether aldosterone per se and in the presence of reactive oxygen stress (H(2)O(2)) enhances collagen abundance in human aortic smooth muscle cell (HAoSMC) media in primary culture and, if so, by which means. Collagen abundance, as well as epidermal growth factor receptor (EGFR) expression and ERK1/2 phosphorylation, was investigated by ELISA and Western blot. Collagenase activity and H(2)O(2) formation were determined by fluorometry and luminometry. Aldosterone alone did not affect collagen abundance but potentiated the stimulatory effect of low concentrations of H(2)O(2) (1-10 micromol/l). This effect disappeared when shedding of membrane-bound EGFR ligands was prevented by GM6001. EGFR expression and cellular EGF responsiveness were enhanced by aldosterone. Inhibition of the EGFR kinase (tyrphostin AG1478) prevented the increase of collagen. The increase in collagen abundance was prevented by blockade of the mineralocorticoid receptor (MR) and could be reproduced by MR transfection into Chinese hamster ovary cells. We conclude that aldosterone sensitizes HAoSMC for H(2)O(2)-induced increase of collagen abundance at least in part by enhanced EGFR expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17242955     DOI: 10.1007/s00424-007-0211-9

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   4.458


  52 in total

1.  Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators.

Authors:  F Zannad; F Alla; B Dousset; A Perez; B Pitt
Journal:  Circulation       Date:  2000-11-28       Impact factor: 29.690

2.  Chronic hyperaldosteronism in a transgenic mouse model fails to induce cardiac remodeling and fibrosis under a normal-salt diet.

Authors:  Qing Wang; Sophie Clement; Giulio Gabbiani; Jean-Daniel Horisberger; Michel Burnier; Bernard C Rossier; Edith Hummler
Journal:  Am J Physiol Renal Physiol       Date:  2004-02-03

3.  Conditional gene expression in renal collecting duct epithelial cells: use of the inducible Cre-lox system.

Authors:  Antoine Ouvrard-Pascaud; Stefania Puttini; Yannis Sainte-Marie; Rafika Athman; Virginie Fontaine; Francoise Cluzeaud; Nicolette Farman; Marie-Edith Rafestin-Oblin; Marcel Blot-Chabaud; Frederic Jaisser
Journal:  Am J Physiol Renal Physiol       Date:  2003-08-19

4.  c-Src-dependent nongenomic signaling responses to aldosterone are increased in vascular myocytes from spontaneously hypertensive rats.

Authors:  Glaucia E Callera; Augusto C I Montezano; Alvaro Yogi; Rita C Tostes; Ying He; Ernesto L Schiffrin; Rhian M Touyz
Journal:  Hypertension       Date:  2005-09-12       Impact factor: 10.190

5.  Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor.

Authors:  J L Arriza; C Weinberger; G Cerelli; T M Glaser; B L Handelin; D E Housman; R M Evans
Journal:  Science       Date:  1987-07-17       Impact factor: 47.728

6.  Eplerenone suppresses constrictive remodeling and collagen accumulation after angioplasty in porcine coronary arteries.

Authors:  M R Ward; P Kanellakis; D Ramsey; J Funder; A Bobik
Journal:  Circulation       Date:  2001-07-24       Impact factor: 29.690

7.  A new phosphospecific cell-based ELISA for p42/p44 mitogen-activated protein kinase (MAPK), p38 MAPK, protein kinase B and cAMP-response-element-binding protein.

Authors:  H H Versteeg; E Nijhuis; G R van den Brink; M Evertzen; G N Pynaert; S J van Deventer; P J Coffer; M P Peppelenbosch
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

8.  Transforming growth factor-alpha mediates nuclear factor kappaB activation in strained arteries.

Authors:  Catherine A Lemarié; Pierre-Louis Tharaux; Bruno Esposito; Alain Tedgui; Stéphanie Lehoux
Journal:  Circ Res       Date:  2006-07-20       Impact factor: 17.367

9.  Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy.

Authors:  Natalia Tsybouleva; Lianfeng Zhang; Suetnee Chen; Rajnikant Patel; Silvia Lutucuta; Shintaro Nemoto; Gilberto DeFreitas; Mark Entman; Blase A Carabello; Robert Roberts; A J Marian
Journal:  Circulation       Date:  2004-03-01       Impact factor: 29.690

10.  Interleukin-1beta induces human proximal tubule cell injury, alpha-smooth muscle actin expression and fibronectin production.

Authors:  David A Vesey; Catherine W Y Cheung; Leila Cuttle; Zoltan A Endre; Glenda Gobé; David W Johnson
Journal:  Kidney Int       Date:  2002-07       Impact factor: 10.612

View more
  7 in total

Review 1.  Mineralocorticoid receptors in vascular function and disease.

Authors:  Amy McCurley; Iris Z Jaffe
Journal:  Mol Cell Endocrinol       Date:  2011-06-24       Impact factor: 4.102

2.  Oxidative stress-related proteins in a Conn's adenoma tissue. Relevance for aldosterone's prooxidative and proinflammatory activity.

Authors:  L A Calò; E Pagnin; P A Davis; D Armanini; P Mormino; G P Rossi; A C Pessina
Journal:  J Endocrinol Invest       Date:  2009-07-21       Impact factor: 4.256

3.  Aldosterone induces elastin production in cardiac fibroblasts through activation of insulin-like growth factor-I receptors in a mineralocorticoid receptor-independent manner.

Authors:  Severa Bunda; Peter Liu; Yanting Wang; Kela Liu; Aleksander Hinek
Journal:  Am J Pathol       Date:  2007-09       Impact factor: 4.307

4.  Actions of aldosterone in the cardiovascular system: the good, the bad, and the ugly?

Authors:  Michael Gekle; Claudia Grossmann
Journal:  Pflugers Arch       Date:  2008-11-19       Impact factor: 3.657

Review 5.  Is the mineralocorticoid receptor a potential target for stroke prevention?

Authors:  Jessica M Osmond; Christine' S Rigsby; Anne M Dorrance
Journal:  Clin Sci (Lond)       Date:  2008-01       Impact factor: 6.124

Review 6.  Mineralocorticoid Receptor and Aldosterone-Related Biomarkers of End-Organ Damage in Cardiometabolic Disease.

Authors:  Stefania Gorini; Vincenzo Marzolla; Caterina Mammi; Andrea Armani; Massimiliano Caprio
Journal:  Biomolecules       Date:  2018-09-18

Review 7.  Atrial Fibrillation and Aortic Ectasia as Complications of Primary Aldosteronism: Focus on Pathophysiological Aspects.

Authors:  Martina Bollati; Chiara Lopez; Fabio Bioletto; Federico Ponzetto; Ezio Ghigo; Mauro Maccario; Mirko Parasiliti-Caprino
Journal:  Int J Mol Sci       Date:  2022-02-14       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.